• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[在从人乳腺癌制备肿瘤相关抗原的框架内进行巨噬细胞黏附抑制试验的经验]

[Experiences with the macrophage adherence inhibition test within the framework of preparing tumor-associated antigens from human breast cancers].

作者信息

Bendix U, Bendix U

出版信息

Allerg Immunol (Leipz). 1985;31(4):273-82.

PMID:2936220
Abstract

We try to prepare tumor-associated antigens from human mammary carcinomas by the use of several biochemical methods and to detect the biologic activity of these antigens with the macrophage adherence inhibition assay. The diagnostic relevance of the macrophage adherence inhibition assay was to improve by optimal enrichment of the tumor-associated antigens. By the use of this test system an enrichment of tumor-associated antigens was not detectable. Our results show, that the macrophage adherence inhibition assay because of its low sensitivity (53%) and the insufficient reproducibility can not be used as test system for tumor immunity in human cancer.

摘要

我们尝试通过几种生化方法从人乳腺癌中制备肿瘤相关抗原,并利用巨噬细胞黏附抑制试验检测这些抗原的生物活性。通过对肿瘤相关抗原进行最佳富集来提高巨噬细胞黏附抑制试验的诊断相关性。使用该检测系统时,未检测到肿瘤相关抗原的富集。我们的结果表明,由于巨噬细胞黏附抑制试验灵敏度低(53%)且重复性不足,不能用作人类癌症肿瘤免疫的检测系统。

相似文献

1
[Experiences with the macrophage adherence inhibition test within the framework of preparing tumor-associated antigens from human breast cancers].[在从人乳腺癌制备肿瘤相关抗原的框架内进行巨噬细胞黏附抑制试验的经验]
Allerg Immunol (Leipz). 1985;31(4):273-82.
2
[Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].[乳腺癌中白细胞黏附抑制试验的机制、动力学和特异性]
Eksp Onkol. 1985;7(6):69-73.
3
[Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas].[巨噬细胞电泳迁移率抑制反应在癌的鉴别诊断中的应用]
Vopr Onkol. 1976;22(12):43-50.
4
Reactivity of serum-armed xenogeneic macrophages to breast cancer antigens.血清武装的异种巨噬细胞对乳腺癌抗原的反应性。
Cancer Res. 1982 Dec;42(12):4985-90.
5
Detection of anti-tumor immunity in man by the indirect macrophage adherence inhibition assay using guinea pig peritoneal cells as indicator cells.以豚鼠腹腔细胞作为指示细胞,通过间接巨噬细胞黏附抑制试验检测人体中的抗肿瘤免疫。
Neoplasma. 1981;28(1):103-10.
6
[Pre- and postoperative reactivity of breast cancer patients to tumor associated antigens and HEP in the macrophage electrophoresis mobility (MEM) test].[乳腺癌患者在巨噬细胞电泳迁移率(MEM)试验中对肿瘤相关抗原和HEP的术前及术后反应性]
Arch Geschwulstforsch. 1982;52(6):469-78.
7
Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.在白细胞黏附抑制试验中,通过针对I类主要组织相容性复合体基因产物的单克隆抗体阻断人T淋巴细胞对自体癌提取物的反应。
Cancer Res. 1984 Jul;44(7):2762-8.
8
Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.人乳腺癌相关CA15-3抗原免疫放射分析的临床评估:与癌胚抗原的比较
Jpn J Clin Oncol. 1986 Dec;16(4):335-46.
9
Serologic detection of breast cancer.
Bull Soc Int Chir. 1974 Mar;33(2):85-90.
10
Macrophage migration inhibition factor test in breast tumors.乳腺肿瘤中的巨噬细胞移动抑制因子检测
Isr J Med Sci. 1986 Nov;22(11):812-6.